DE3348370C2
(de)
*
|
1982-10-08 |
2001-10-11 |
Glaxo Group Ltd |
Medikamenten-Packung und Verfahren zur Erzeugung eines zur Inhalation bestimmten Medikamenten-Pulver-Luftstroms
|
SE448277B
(sv)
*
|
1985-04-12 |
1987-02-09 |
Draco Ab |
Indikeringsanordning vid en doseringsanordning for lekemedel
|
PH26882A
(en)
*
|
1985-07-30 |
1992-11-16 |
Glaxo Group Ltd |
Devices for administering medicaments to patients
|
SE8605130L
(sv)
*
|
1986-07-24 |
1988-01-25 |
Marcus Diamant |
Redskap for utklemning av tabletter fran tablettkartor och liknande
|
US4817800A
(en)
*
|
1987-05-20 |
1989-04-04 |
Surgikos, Inc. |
Fluid injection system cassette and fluid packaging methods
|
FR2626500B1
(fr)
*
|
1988-01-28 |
1990-04-27 |
Valois Sa |
Poussoir de vaporisateur agence pour operer le melange d'un additif dans l'emission du jet
|
CH678151A5
(en)
*
|
1988-07-13 |
1991-08-15 |
Heinz Hermann Weick |
Self-medication nasal dispenser
|
GB8914223D0
(en)
*
|
1989-06-21 |
1989-08-09 |
Fisons Plc |
Medicament container
|
US5239991A
(en)
*
|
1989-06-21 |
1993-08-31 |
Fisons Plc |
Disposable powder medicament inhalation device with peel-off cover
|
IT1230313B
(it)
*
|
1989-07-07 |
1991-10-18 |
Somova Spa |
Inalatore per medicamenti in capsule.
|
DE3927170A1
(de)
*
|
1989-08-17 |
1991-02-21 |
Boehringer Ingelheim Kg |
Inhalator
|
US5009561A
(en)
*
|
1989-08-18 |
1991-04-23 |
Pharmacia Diagnostics Inc. |
Reagent tablet dispenser
|
UA26230A
(uk)
*
|
1990-03-02 |
1999-07-19 |
Глексо Груп Лімітед |
Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
SK280967B6
(sk)
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
GB9012870D0
(en)
*
|
1990-06-08 |
1990-08-01 |
Glaxo Group Ltd |
Device
|
DE4021263C2
(de)
*
|
1990-07-04 |
1996-04-11 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung für Medien
|
IT1243344B
(it)
*
|
1990-07-16 |
1994-06-10 |
Promo Pack Sa |
Inalatore plurimonodose per medicamenti in polvere
|
GB9021433D0
(en)
*
|
1990-10-02 |
1990-11-14 |
Atomic Energy Authority Uk |
Power inhaler
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
US5042472A
(en)
*
|
1990-10-15 |
1991-08-27 |
Merck & Co., Inc. |
Powder inhaler device
|
NL9002706A
(nl)
*
|
1990-12-10 |
1992-07-01 |
Pharmachemie Bv |
Inrichting ten gebruike bij het inhaleren van in staafvormige capsules verpakte poedervormige stoffen.
|
GB2253200A
(en)
*
|
1991-02-01 |
1992-09-02 |
Harris Pharma Ltd |
Inhalation apparatus and fracturable capsule for use therewith
|
US5243970A
(en)
*
|
1991-04-15 |
1993-09-14 |
Schering Corporation |
Dosing device for administering metered amounts of powdered medicaments to patients
|
US5327883A
(en)
*
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
US6681767B1
(en)
|
1991-07-02 |
2004-01-27 |
Nektar Therapeutics |
Method and device for delivering aerosolized medicaments
|
US5337740A
(en)
*
|
1991-08-01 |
1994-08-16 |
New England Pharmaceuticals, Inc. |
Inhalation devices
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
DE4142238A1
(de)
*
|
1991-12-20 |
1993-06-24 |
Boehringer Ingelheim Kg |
Pulverinhalator mit pulvertraeger aus regelmaessigen mikrostrukturen
|
GB2264237A
(en)
*
|
1992-02-05 |
1993-08-25 |
Robert Edward Newell |
An inhaler
|
GB9203761D0
(en)
*
|
1992-02-21 |
1992-04-08 |
Innovata Biomed Ltd |
Inhaler
|
US5301664A
(en)
*
|
1992-03-06 |
1994-04-12 |
Sievers Robert E |
Methods and apparatus for drug delivery using supercritical solutions
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
US5785049A
(en)
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
KR0177265B1
(ko)
*
|
1992-10-19 |
1999-04-01 |
미첼 알. 우드베리 |
건분말 흡입기
|
SE9203743D0
(sv)
|
1992-12-11 |
1992-12-11 |
Astra Ab |
Efficient use
|
US6250300B1
(en)
|
1992-12-11 |
2001-06-26 |
Ab Astra |
System for dispensing pharmaceutically active compounds
|
US5368187A
(en)
*
|
1993-01-19 |
1994-11-29 |
Poncetta; Stanley |
Method and apparatus for dispensing materials from blister packages
|
US7448375B2
(en)
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US5743250A
(en)
|
1993-01-29 |
1998-04-28 |
Aradigm Corporation |
Insulin delivery enhanced by coached breathing
|
US5873358A
(en)
*
|
1993-01-29 |
1999-02-23 |
Aradigm Corporation |
Method of maintaining a diabetic patient's blood glucose level in a desired range
|
US5819726A
(en)
*
|
1993-01-29 |
1998-10-13 |
Aradigm Corporation |
Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
|
US5970973A
(en)
*
|
1993-01-29 |
1999-10-26 |
Aradigm Corporation |
Method of delivering insulin lispro
|
US6012450A
(en)
*
|
1993-01-29 |
2000-01-11 |
Aradigm Corporation |
Intrapulmonary delivery of hematopoietic drug
|
US6098620A
(en)
*
|
1993-01-29 |
2000-08-08 |
Aradigm Corporation |
Device for aerosolizing narcotics
|
US5672581A
(en)
*
|
1993-01-29 |
1997-09-30 |
Aradigm Corporation |
Method of administration of insulin
|
US5934272A
(en)
*
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
US5724957A
(en)
*
|
1993-01-29 |
1998-03-10 |
Aradigm Corporation |
Intrapulmonary delivery of narcotics
|
US5888477A
(en)
|
1993-01-29 |
1999-03-30 |
Aradigm Corporation |
Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
|
US5558085A
(en)
*
|
1993-01-29 |
1996-09-24 |
Aradigm Corporation |
Intrapulmonary delivery of peptide drugs
|
US5915378A
(en)
*
|
1993-01-29 |
1999-06-29 |
Aradigm Corporation |
Creating an aerosolized formulation of insulin
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US6131567A
(en)
*
|
1993-01-29 |
2000-10-17 |
Aradigm Corporation |
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
|
JPH08507452A
(ja)
*
|
1993-03-03 |
1996-08-13 |
テナックス コーポレーション |
乾燥粉末状吸入器薬剤の担体
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
US5372128A
(en)
*
|
1993-04-14 |
1994-12-13 |
Habley Medical Technology Corporation |
Fluidizing powder inhaler
|
US5497763A
(en)
*
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
US5709202A
(en)
*
|
1993-05-21 |
1998-01-20 |
Aradigm Corporation |
Intrapulmonary delivery of aerosolized formulations
|
US5533502A
(en)
*
|
1993-05-28 |
1996-07-09 |
Vortran Medical Technology, Inc. |
Powder inhaler with aerosolization occurring within each individual powder receptacle
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
EP1462096B1
(en)
|
1994-03-07 |
2008-12-10 |
Nektar Therapeutics |
Methods and compositions for pulmonary delivery of insulin
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US5664557A
(en)
*
|
1994-03-10 |
1997-09-09 |
Respiratory Delivery Systems, Inc. |
Releasably engageable coupling for an inhaler
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
GB9409851D0
(en)
*
|
1994-05-17 |
1994-07-06 |
Cambridge Consultants |
Improvements in and relating to containers of particulate material
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
CZ289029B6
(cs)
*
|
1994-09-21 |
2001-10-17 |
Inhale Therapeutic Systems |
Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
|
US5522385A
(en)
*
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
FR2725626A1
(fr)
*
|
1994-10-18 |
1996-04-19 |
Sofab |
Dispositif pour l'inhalation de produits en poudre
|
DE19500764C2
(de)
*
|
1995-01-13 |
2001-09-27 |
Sofotec Gmbh & Co Kg |
Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form
|
DE19502725B4
(de)
*
|
1995-01-28 |
2004-03-04 |
Ing. Erich Pfeiffer Gmbh & Co Kg |
Austragvorrichtung für Medien
|
US5676643A
(en)
*
|
1995-02-13 |
1997-10-14 |
The Procter & Gamble Company |
Dispenser for friably releasing dry particulate medicaments
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US5714007A
(en)
*
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
DE19523516C1
(de)
*
|
1995-06-30 |
1996-10-31 |
Asta Medica Ag |
Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
US5692496A
(en)
*
|
1995-08-02 |
1997-12-02 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5823183A
(en)
*
|
1995-08-02 |
1998-10-20 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5988163A
(en)
*
|
1995-08-02 |
1999-11-23 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
|
US6209538B1
(en)
*
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
NL1001031C1
(nl)
*
|
1995-08-23 |
1997-02-25 |
Npk Ind Design B V |
Inrichting voor het afgeven van pillen uit een blisterverpakking.
|
ES2216418T3
(es)
|
1995-12-07 |
2004-10-16 |
Jago Research Ag |
Boquilla para un inhalador para la administracion de varias dosis de un polvo seco farmacologico.
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
US5823179A
(en)
|
1996-02-13 |
1998-10-20 |
1263152 Ontario Inc. |
Nebulizer apparatus and method
|
US5743251A
(en)
|
1996-05-15 |
1998-04-28 |
Philip Morris Incorporated |
Aerosol and a method and apparatus for generating an aerosol
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
WO1998029141A1
(en)
|
1996-12-31 |
1998-07-09 |
Inhale Therapeutic Systems, Inc. |
Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
DE19704849B4
(de)
*
|
1997-02-08 |
2011-02-17 |
Ing. Erich Pfeiffer Gmbh |
Austragvorrichtung für Medien
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5915560A
(en)
*
|
1997-05-03 |
1999-06-29 |
George; Donald C. |
Compartmentalized pill dispenser
|
US5909822A
(en)
*
|
1997-05-03 |
1999-06-08 |
George; Donald C. |
Pill dispenser employing a sealed pill carrier
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
WO1999027987A1
(en)
|
1997-12-02 |
1999-06-10 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CA2315777C
(en)
|
1998-01-16 |
2008-12-23 |
1263152 Ontario Inc. |
Indicating device for use with a dispensing device
|
BR9908771A
(pt)
|
1998-03-16 |
2000-12-12 |
Inhale Therapeutic Syst |
Processos para a liberação de um agente ativo e de insulina para os pulmões de um paciente humano, dispositivo para aumentar a biodisponibilidade de um agente ativo, e, dispositivos para a liberação de um agente ativo e de insulina para os pulmões de um paciente humano
|
US6336453B1
(en)
|
1999-04-30 |
2002-01-08 |
Trudell Medical International |
Indicating device for aerosol container
|
US6082358A
(en)
|
1998-05-05 |
2000-07-04 |
1263152 Ontario Inc. |
Indicating device for aerosol container
|
US6729330B2
(en)
|
1998-05-05 |
2004-05-04 |
Trudell Medical International |
Indicating device for aerosol container
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US6149774A
(en)
*
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
DE19831525A1
(de)
*
|
1998-07-14 |
2000-01-20 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
UA73924C2
(en)
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
US6234167B1
(en)
|
1998-10-14 |
2001-05-22 |
Chrysalis Technologies, Incorporated |
Aerosol generator and methods of making and using an aerosol generator
|
US6923979B2
(en)
*
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
US7207330B1
(en)
|
1999-06-05 |
2007-04-24 |
Innovata Biomed Limited |
Delivery system
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
US6730066B1
(en)
*
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
US6810872B1
(en)
*
|
1999-12-10 |
2004-11-02 |
Unisia Jecs Corporation |
Inhalant medicator
|
US6679256B2
(en)
|
1999-12-17 |
2004-01-20 |
Nektar Therapeutics |
Systems and methods for extracting powders from receptacles
|
US7069929B2
(en)
*
|
2000-02-01 |
2006-07-04 |
Quadrant Technologies Limited |
Dry powder inhaler
|
US6427688B1
(en)
*
|
2000-02-01 |
2002-08-06 |
Dura Pharmaceuticals, Icn. |
Dry powder inhaler
|
CA2401288A1
(en)
|
2000-02-28 |
2001-09-07 |
Vectura Limited |
Improvements in or relating to the delivery of oral drugs
|
US6883516B2
(en)
|
2000-04-27 |
2005-04-26 |
Chrysalis Technologies Incorporated |
Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
|
MY136453A
(en)
|
2000-04-27 |
2008-10-31 |
Philip Morris Usa Inc |
"improved method and apparatus for generating an aerosol"
|
US6948494B1
(en)
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
GB0015034D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
TWI224515B
(en)
*
|
2000-06-23 |
2004-12-01 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
US7575761B2
(en)
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
AU7576001A
(en)
|
2000-08-05 |
2002-02-18 |
Glaxo Group Ltd |
6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
|
AU2001286518A1
(en)
*
|
2000-08-15 |
2002-02-25 |
University Of Kentucky Research Foundation |
Programmable multi-dose intranasal drug delivery device
|
US6491233B2
(en)
|
2000-12-22 |
2002-12-10 |
Chrysalis Technologies Incorporated |
Vapor driven aerosol generator and method of use thereof
|
US6501052B2
(en)
|
2000-12-22 |
2002-12-31 |
Chrysalis Technologies Incorporated |
Aerosol generator having multiple heating zones and methods of use thereof
|
US6799572B2
(en)
|
2000-12-22 |
2004-10-05 |
Chrysalis Technologies Incorporated |
Disposable aerosol generator system and methods for administering the aerosol
|
US6701921B2
(en)
|
2000-12-22 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater in multilayered composite and method of use thereof
|
US6681998B2
(en)
|
2000-12-22 |
2004-01-27 |
Chrysalis Technologies Incorporated |
Aerosol generator having inductive heater and method of use thereof
|
US7077130B2
(en)
|
2000-12-22 |
2006-07-18 |
Chrysalis Technologies Incorporated |
Disposable inhaler system
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
CA2809180C
(en)
|
2001-03-20 |
2015-06-02 |
Trudell Medical International |
Nebulizer apparatus with an adjustable fluid orifice
|
JP4143413B2
(ja)
|
2001-03-22 |
2008-09-03 |
グラクソ グループ リミテッド |
β2−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体
|
EP1383786B1
(en)
|
2001-04-30 |
2008-10-15 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
US6745760B2
(en)
|
2001-05-15 |
2004-06-08 |
Trudell Medical International |
Medicament applicator
|
US8061006B2
(en)
|
2001-07-26 |
2011-11-22 |
Powderject Research Limited |
Particle cassette, method and kit therefor
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
ES2316599T3
(es)
|
2001-09-14 |
2009-04-16 |
Glaxo Group Limited |
Derivados de fenetanolamina para el tratamiento de enfermedades respiratorias.
|
WO2003024396A2
(en)
|
2001-09-17 |
2003-03-27 |
Glaxo Group Limited |
Dry powder medicament formulations
|
US6871647B2
(en)
|
2001-09-19 |
2005-03-29 |
Advent Pharmaceuticals Pty Ltd |
Inhaler
|
US6568390B2
(en)
|
2001-09-21 |
2003-05-27 |
Chrysalis Technologies Incorporated |
Dual capillary fluid vaporizing device
|
US6640050B2
(en)
|
2001-09-21 |
2003-10-28 |
Chrysalis Technologies Incorporated |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
US6681769B2
(en)
|
2001-12-06 |
2004-01-27 |
Crysalis Technologies Incorporated |
Aerosol generator having a multiple path heater arrangement and method of use thereof
|
US6804458B2
(en)
*
|
2001-12-06 |
2004-10-12 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
|
US6701922B2
(en)
|
2001-12-20 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Mouthpiece entrainment airflow control for aerosol generators
|
US7458373B2
(en)
|
2002-01-15 |
2008-12-02 |
Philip Morris Usa Inc. |
Aerosol generator for drug formulation
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
US20060187750A1
(en)
*
|
2002-03-01 |
2006-08-24 |
Victor Aldrich |
Rotary blending apparatus and system
|
WO2003078448A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
US7004164B2
(en)
|
2002-03-21 |
2006-02-28 |
Trudell Medical International |
Indicating device for aerosol container
|
US7448184B2
(en)
*
|
2002-03-26 |
2008-11-11 |
Glaxo Group Limited |
Method for forming a laminate assembly with an ultrasonic welder
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
DE10217929A1
(de)
*
|
2002-04-22 |
2003-11-06 |
Sixp Ag |
Vorrichtung zur Ausgabe von Tabletten
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
EP1497261B1
(en)
*
|
2002-04-25 |
2007-12-19 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
AU2003228683A1
(en)
*
|
2002-04-25 |
2003-11-10 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
GB2388040B
(en)
*
|
2002-05-02 |
2005-12-14 |
Robert Jeremy West |
Nicotine inhalation device
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
WO2003095005A1
(en)
*
|
2002-05-10 |
2003-11-20 |
Chrysalis Technologies Incorporated |
Aerosol generator for drug formulation and methods of generating aerosol
|
AU2003269872A1
(en)
*
|
2002-05-15 |
2003-12-31 |
Glaxo Group Limited |
Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging
|
US6904908B2
(en)
*
|
2002-05-21 |
2005-06-14 |
Trudell Medical International |
Visual indicator for an aerosol medication delivery apparatus and system
|
US7185651B2
(en)
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
WO2004011068A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Glaxo Group Limited |
Medicament dispenser
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
AU2003250166A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Glaxo Group Limited |
Medicament dispenser
|
AU2003270321B2
(en)
|
2002-09-06 |
2008-04-03 |
Philip Morris Products S.A. |
Aerosol generating devices and methods for generating aerosols having controlled particle sizes
|
US20070139442A1
(en)
*
|
2002-09-13 |
2007-06-21 |
Robinson Karl E |
Coated blending system
|
US6772757B2
(en)
|
2002-10-25 |
2004-08-10 |
Chrysalis Technologies Incorporated |
Concentric controlled temperature profile fluid vaporizing device
|
DE60320007T2
(de)
|
2002-10-28 |
2009-06-18 |
Glaxo Group Ltd., Greenford |
Phenthanolamin-Derivate zur Behandlung von Atemwegserkrankungen
|
AU2003293361A1
(en)
*
|
2002-12-18 |
2004-07-29 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
JP2006516517A
(ja)
*
|
2003-02-05 |
2006-07-06 |
テッダム,マーティン,ジョン |
ディスペンサー
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
EP1488819A1
(en)
*
|
2003-06-16 |
2004-12-22 |
Rijksuniversiteit te Groningen |
Dry powder inhaler and method for pulmonary inhalation of dry powder
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
AR045914A1
(es)
|
2003-07-17 |
2005-11-16 |
Glaxo Group Ltd |
Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
|
US7367334B2
(en)
|
2003-08-27 |
2008-05-06 |
Philip Morris Usa Inc. |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
AP2007004238A0
(en)
|
2003-10-14 |
2007-12-31 |
Glaxo Group Ltd |
Muscarinic acetycholine receptor antagonists
|
AU2004281167A1
(en)
|
2003-10-17 |
2005-04-28 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists field of the invention
|
US20070277820A1
(en)
*
|
2003-10-27 |
2007-12-06 |
Timothy Crowder |
Blister packages and associated methods of fabricating dry powder drug containment systems
|
US7621273B2
(en)
|
2003-10-28 |
2009-11-24 |
Trudell Medical International |
Indicating device with warning dosage indicator
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
AU2004294889B2
(en)
*
|
2003-12-03 |
2010-08-26 |
Boehringer Ingelheim International Gmbh |
Medical product containing tiotropium
|
US7100530B2
(en)
|
2003-12-15 |
2006-09-05 |
Trudell Medical International, Inc. |
Dose indicating device
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US8147426B2
(en)
*
|
2003-12-31 |
2012-04-03 |
Nipro Diagnostics, Inc. |
Integrated diagnostic test system
|
EP1725564A4
(en)
|
2004-03-17 |
2007-09-12 |
Glaxo Group Ltd |
ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR
|
US7846973B2
(en)
|
2004-04-02 |
2010-12-07 |
Theravance, Inc. |
Chemical process and new crystalline form
|
WO2005102429A1
(en)
|
2004-04-21 |
2005-11-03 |
Innovata Biomed Limited |
Inhaler
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
WO2005112644A2
(en)
|
2004-05-13 |
2005-12-01 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists
|
GB0418738D0
(en)
*
|
2004-08-23 |
2004-09-22 |
3M Innovative Properties Co |
Medicinal aerosol formulation receptacle and production thereof
|
US7543582B2
(en)
|
2004-09-20 |
2009-06-09 |
Trudell Medical International |
Dose indicating device with display elements attached to container
|
EP1827541B1
(de)
*
|
2004-10-21 |
2013-05-29 |
Boehringer Ingelheim International GmbH |
Blister für inhalatoren
|
US8165460B2
(en)
*
|
2004-10-26 |
2012-04-24 |
The University Of North Carolina At Chapel Hill |
Coated filament for evaporation/condensation aerosol generation of therapeutic agents and methods for using
|
JP2006130143A
(ja)
*
|
2004-11-08 |
2006-05-25 |
Hitachi Ltd |
吸入式投薬器及び薬剤カートリッジ
|
WO2006053059A2
(en)
*
|
2004-11-12 |
2006-05-18 |
Glaxo Group Limited |
Sensor system with acoustic transducer
|
EP1838371B1
(en)
|
2005-01-20 |
2020-09-09 |
Trudell Medical International |
Dispensing device
|
WO2006084033A1
(en)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
WO2006086270A1
(en)
|
2005-02-10 |
2006-08-17 |
Glaxo Group Limited |
Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
|
TW200724142A
(en)
|
2005-03-25 |
2007-07-01 |
Glaxo Group Ltd |
Novel compounds
|
AR053346A1
(es)
|
2005-03-25 |
2007-05-02 |
Glaxo Group Ltd |
Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38
|
GB0507711D0
(en)
|
2005-04-15 |
2005-05-25 |
Vectura Group Plc |
Improved blister piercing
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
US8653028B2
(en)
*
|
2005-04-29 |
2014-02-18 |
Rui Rong Yuan |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
EP1879579A1
(en)
*
|
2005-05-04 |
2008-01-23 |
Boehringer Ingelheim International GmbH |
Inhalation device containing plural doses of a pharmaceutical composition
|
DE102005035705A1
(de)
*
|
2005-07-27 |
2007-02-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arzneimittelblister
|
US7767691B2
(en)
|
2005-08-18 |
2010-08-03 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
US20070049641A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Rabindra Tirouvanziam |
Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
US20130131007A1
(en)
|
2005-09-07 |
2013-05-23 |
Bebaas, Inc. |
Vitamin b12 compositions
|
US20070178141A1
(en)
*
|
2005-09-07 |
2007-08-02 |
Bebaas, Inc. |
Vitamin B12 compositions
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
EP1795221A1
(en)
*
|
2005-12-02 |
2007-06-13 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
US8037880B2
(en)
*
|
2006-04-07 |
2011-10-18 |
The University Of Western Ontario |
Dry powder inhaler
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
EP1844809A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
|
DE102006043637A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Zerstäuber
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
US8141550B2
(en)
|
2006-08-01 |
2012-03-27 |
Trudell Medical International |
Dispensing device
|
US8161966B2
(en)
*
|
2006-08-21 |
2012-04-24 |
Trudell Medical International |
Respiratory muscle endurance training device and method for the use thereof
|
DE102006045788A1
(de)
|
2006-09-26 |
2008-03-27 |
Alfred Von Schuckmann |
Spender für pulverförmige Massen
|
JP2010508069A
(ja)
|
2006-10-25 |
2010-03-18 |
ノバルティス アーゲー |
パウダー分散装置、その装置の製造方法および使用方法、その装置および他の装置に使用される構成要素
|
GB0621957D0
(en)
*
|
2006-11-03 |
2006-12-13 |
Vectura Group Plc |
Inhaler devices and bespoke pharmaceutical compositions
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
CA2886385A1
(en)
|
2007-01-09 |
2008-07-17 |
Mystic Pharmaceuticals, Inc. |
Intranasal cartridge devices
|
ES2476842T3
(es)
*
|
2007-01-10 |
2014-07-15 |
Purdue Research Foundation |
Inhibidores polipept�dicos de HSP27 quinasa y usos de los mismos
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
EP1992374A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992378A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992379A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992380A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992372A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992373A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992376A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992377A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
US9248076B2
(en)
|
2007-05-16 |
2016-02-02 |
Mystic Pharmaceuticals, Inc. |
Dose dispensing containers
|
AT505246B8
(de)
*
|
2007-06-01 |
2009-06-15 |
Croma Pharma Gmbh |
Container für eine mehrzahl von einzeldosen sowie applikator für derartige container
|
PE20090136A1
(es)
*
|
2007-06-01 |
2009-03-11 |
Boehringer Ingelheim Int |
Dispositivo dispensador
|
JP5703466B2
(ja)
*
|
2007-08-07 |
2015-04-22 |
パーデュー・リサーチ・ファウンデーションPurdue Research Foundation |
キナーゼ阻害薬およびその使用
|
EP2042208A1
(en)
*
|
2007-09-25 |
2009-04-01 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
EP2082763A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
CA2716124A1
(en)
*
|
2008-02-20 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Powder inhalers
|
CA2884941C
(en)
|
2008-02-21 |
2017-03-14 |
Martin P. Foley |
Respiratory muscle endurance training device
|
US20090235929A1
(en)
*
|
2008-03-19 |
2009-09-24 |
Marc Egen |
Powder inhalers
|
US8082873B2
(en)
|
2008-05-05 |
2011-12-27 |
Trudell Medical International |
Drive mechanism for an indicating device
|
EP2326339A4
(en)
*
|
2008-05-21 |
2012-06-20 |
Neurotez Inc |
METHOD FOR TREATING PROGRESSIVE COGNITIVE DISORDER IN CONNECTION WITH NEUROFIBRILLARY TANGLES
|
US8181591B1
(en)
|
2008-05-23 |
2012-05-22 |
Trudell Medical International |
Domed actuator for indicating device
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
WO2010036355A2
(en)
*
|
2008-09-26 |
2010-04-01 |
Oriel Therapeutics, Inc. |
Inhaler mechanisms with radially biased piercers and related methods
|
AU2009296535B2
(en)
|
2008-09-26 |
2013-04-18 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with dual piercing members and related devices and methods
|
JP5592381B2
(ja)
|
2008-09-26 |
2014-09-17 |
オリエル・セラピューティクス,インコーポレイテッド |
個別気道通路を有する吸入器ならびに関連するディスクおよび方法
|
US9050427B2
(en)
*
|
2008-09-30 |
2015-06-09 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
ES2561899T3
(es)
*
|
2008-10-01 |
2016-03-01 |
Oriel Therapeutics, Inc. |
Inhaladores de polvo seco con mecanismos de perforación giratorios y dispositivos y métodos relacionados
|
RU2514318C2
(ru)
*
|
2008-10-08 |
2014-04-27 |
Астразенека Аб |
Ингалятор со звуковыми индикаторными средствами
|
JP5785085B2
(ja)
*
|
2008-10-20 |
2015-09-24 |
モイライ マトリックス インコーポレイテッド |
癒着を処置又は防止するためのポリペプチド
|
ES2402241T3
(es)
|
2008-10-22 |
2013-04-30 |
Trudell Medical International |
Sistema de suministro de aerosol modular
|
WO2010054017A1
(en)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
|
EP2373366B1
(de)
*
|
2008-12-03 |
2016-02-17 |
Boehringer Ingelheim International GmbH |
Inhalator
|
CN102316731B
(zh)
*
|
2008-12-10 |
2016-06-01 |
普渡研究基金会 |
基于细胞渗透性肽的激酶抑制剂
|
GB0901520D0
(en)
*
|
2009-01-30 |
2009-03-11 |
Vectura Delivery Devices Ltd |
Inhaler
|
PL2400950T3
(pl)
|
2009-02-26 |
2019-12-31 |
Glaxo Group Limited |
Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
|
US9119924B2
(en)
|
2009-03-17 |
2015-09-01 |
Boehringer Ingelheim International Gmbh |
Dispensing device, storage device and method for dispensing a formulation
|
EP2432536B1
(en)
*
|
2009-05-21 |
2018-07-04 |
MicroDose Therapeutx, Inc. |
Rotary cassette system for dry powder inhaler
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
CN102834406A
(zh)
|
2009-06-16 |
2012-12-19 |
默沙东公司 |
作为糖皮质激素受体激动剂的新的[3.2-c]杂芳基甾体、其组合物和用途
|
CA2768963C
(en)
|
2009-07-24 |
2019-11-26 |
Amazentis Sa |
Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
|
US9890195B2
(en)
*
|
2009-07-27 |
2018-02-13 |
Purdue Research Foundation |
MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
EP3431128A1
(en)
|
2010-01-05 |
2019-01-23 |
MicroDose Therapeutx, Inc. |
Inhalation device and method
|
US8135497B2
(en)
|
2010-01-13 |
2012-03-13 |
Joslyn Matthew I |
Portable, personal medication dispensing apparatus and method
|
DK2547307T3
(en)
|
2010-03-18 |
2014-12-08 |
Medcomb Holding Aps |
SYSTEM FOR OPENING A MEDICAL BLISTER PACKAGE
|
USD635246S1
(en)
|
2010-03-26 |
2011-03-29 |
Oriel Therapeutics, Inc. |
Dose disk for dry powder inhalers
|
USD641076S1
(en)
|
2010-03-26 |
2011-07-05 |
Oriel Therapeutics, Inc. |
Dry powder inhaler
|
US20130157991A1
(en)
|
2010-08-31 |
2013-06-20 |
Osama Ahmed Aswania |
Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same
|
EP3461474B1
(en)
|
2010-08-31 |
2020-11-11 |
GlaxoSmithKline Intellectual Property Development Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
USD666098S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666492S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
USD666099S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666493S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
USD666097S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666096S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
WO2012064286A1
(en)
|
2010-11-11 |
2012-05-18 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
SG10201604560TA
(en)
|
2011-04-12 |
2016-07-28 |
Moerae Matrix Inc |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
SG195038A1
(en)
|
2011-05-19 |
2013-12-30 |
Savara Inc |
Dry powder vancomycin compositions and associated methods
|
US8585659B2
(en)
|
2011-05-31 |
2013-11-19 |
Mystic Pharmaceuticals, Inc. |
Piercing device for drug delivery systems
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
WO2013134636A1
(en)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
WO2013160418A1
(en)
|
2012-04-27 |
2013-10-31 |
Glaxo Group Limited |
Novel compounds
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
WO2014039533A2
(en)
|
2012-09-04 |
2014-03-13 |
Eleison Pharmaceuticals, Llc |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
CA2891348C
(en)
|
2012-11-28 |
2020-04-28 |
Intercept Pharmaceuticals, Inc. |
Treatment of pulmonary disease
|
GB201301192D0
(en)
|
2013-01-23 |
2013-03-06 |
Vectura Delivery Devices Ltd |
A blister piercing element for a dry powder inhaler
|
JP2015037466A
(ja)
*
|
2013-04-08 |
2015-02-26 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
AU2014318821B2
(en)
|
2013-09-10 |
2018-04-19 |
Board Of Regents Of The University Of Texas System |
Therapeutics targeting truncated Adenomatous Polyposis Coli (APC) proteins
|
CA2936301C
(en)
|
2013-10-15 |
2021-06-08 |
Mystic Pharmaceuticals, Inc. |
Controllable rate turbulating nozzle
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
AU2015250132B2
(en)
*
|
2014-04-24 |
2020-11-26 |
Questa Corporation |
Multi-size pill splitter and methods
|
PE20170185A1
(es)
|
2014-05-12 |
2017-04-01 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Composiciones farmaceuticas para tratar enfermedades infecciosas
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
BR112017008923A2
(pt)
|
2014-10-31 |
2017-12-26 |
Glaxosmithkline Ip Dev Ltd |
?formulação em pó?
|
KR20170083063A
(ko)
|
2014-11-17 |
2017-07-17 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법
|
ES2796973T3
(es)
|
2014-12-10 |
2020-11-30 |
Hyperstem Sa |
Métodos y composiciones para reducir el crecimiento, la migración y la invasividad de células madre de cáncer cerebral y mejorar la supervivencia de pacientes con tumores cerebrales
|
USD754919S1
(en)
*
|
2014-12-19 |
2016-04-26 |
Fontem Holdings 4 B.V. |
Mouthpiece
|
SG11201705559RA
(en)
|
2015-01-08 |
2017-08-30 |
Moerae Matrix Inc |
Formulation of mk2 inhibitor peptides
|
EP3247322A4
(en)
|
2015-01-21 |
2018-08-29 |
Mylan Inc. |
Medication packaging and dose regimen system
|
WO2016142426A1
(en)
|
2015-03-11 |
2016-09-15 |
Glaxosmithkline Intellectual Property Development Limited |
Tslp binding proteins
|
US9999655B2
(en)
|
2015-03-12 |
2018-06-19 |
Moerae Matrix, Inc. |
Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
|
CA2986797A1
(en)
*
|
2015-05-22 |
2016-12-01 |
Compressed Perforated Puck Technologies Inc. |
Vaporizer apparatus for compressed tablet and loose fill plant source materials
|
EP3307069B1
(en)
|
2015-06-10 |
2021-08-04 |
Hackensack University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
WO2016202253A1
(en)
|
2015-06-15 |
2016-12-22 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 regulators
|
KR20180017038A
(ko)
|
2015-06-15 |
2018-02-20 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Nrf2 조절제
|
KR20180018684A
(ko)
|
2015-06-15 |
2018-02-21 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Nrf2 조절제
|
WO2017007634A1
(en)
|
2015-07-06 |
2017-01-12 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
AU2016292779B2
(en)
|
2015-07-15 |
2021-05-20 |
The Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
JP2018529744A
(ja)
|
2015-10-06 |
2018-10-11 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのアリールシクロヘキシルピラゾール
|
EP3359532A1
(en)
|
2015-10-06 |
2018-08-15 |
GlaxoSmithKline Intellectual Property Development Limited |
Biaryl pyrazoles as nrf2 regulators
|
BR112018009899A8
(pt)
|
2015-11-18 |
2019-02-26 |
Glaxosmithkline Ip No 2 Ltd |
composição, inalador, forma de dosagem única, métodos para fabricar partículas, para melhorar as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a incidência das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a gravidade das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir uma infecção respiratória viral e para fabricar uma partícula de inalação de pó seco de ribavirina controlada na forma polimorfa cristalina, partículas fabricadas, método de tratamento, pluralidade de partículas, e, recipiente de dose.
|
AU2017210319A1
(en)
|
2016-01-20 |
2018-08-23 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
MX2018014121A
(es)
|
2016-05-19 |
2019-04-29 |
Trudell Medical Int |
Camara de retencion con valvula inteligente.
|
US10786638B2
(en)
|
2016-07-08 |
2020-09-29 |
Trudell Medical International |
Nebulizer apparatus and method
|
CA3028604C
(en)
|
2016-07-08 |
2023-12-05 |
Trudell Medical International |
Smart oscillating positive expiratory pressure device
|
US11260049B2
(en)
|
2016-09-20 |
2022-03-01 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
TRPV4 antagonists
|
WO2018055527A1
(en)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Trpv4 antagonists
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
KR20190088404A
(ko)
|
2016-12-06 |
2019-07-26 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도
|
CN110049795B
(zh)
|
2016-12-09 |
2022-07-19 |
特鲁德尔医学国际公司 |
智能雾化器
|
WO2018109642A1
(en)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
EP3551620A1
(en)
|
2016-12-12 |
2019-10-16 |
GlaxoSmithKline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
JP2020502129A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしての3−オキソ−1,4−ジアゼピニル化合物
|
US11117905B2
(en)
|
2016-12-14 |
2021-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as NRF2 activators
|
EP3555088B1
(en)
|
2016-12-14 |
2021-11-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Bisaryl amides as nrf2 regulators
|
JP2020502152A
(ja)
|
2016-12-15 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしてのエーテル結合トリアゾール
|
CA3044773A1
(en)
|
2016-12-15 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activators
|
CN108328122B
(zh)
*
|
2017-01-17 |
2024-04-12 |
李和伟 |
一种制剂盒
|
TWI778052B
(zh)
|
2017-04-24 |
2022-09-21 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
US20210177861A1
(en)
|
2017-12-11 |
2021-06-17 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
MX2020007026A
(es)
|
2018-01-04 |
2020-12-03 |
Trudell Medical Int |
Dispositivo de presión espiratoria positiva oscilante inteligente.
|
TWI795510B
(zh)
|
2018-01-17 |
2023-03-11 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
PI4KIIIβ抑制劑
|
CN108815653B
(zh)
*
|
2018-04-19 |
2020-11-10 |
山西白求恩医院 |
一种气体速度可调节的雾化器
|
US11643407B2
(en)
|
2018-05-23 |
2023-05-09 |
Glaxosmithkline Intellectual Property Development Limited |
Indanes as NRF2 activators
|
MX2021000917A
(es)
|
2018-07-27 |
2021-06-23 |
Cocrystal Pharma Inc |
Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
ES2937837T3
(es)
|
2018-09-10 |
2023-03-31 |
Cocrystal Pharma Inc |
Inhibidores de piridopirazina y piridotriazina de la replicación del virus de la gripe
|
DK3866778T3
(da)
|
2018-10-17 |
2023-02-20 |
Cocrystal Pharma Inc |
Kombinationer af hæmmere af influenzavirusreplikation
|
KR20210091753A
(ko)
|
2018-11-13 |
2021-07-22 |
코크리스탈 파마, 아이엔씨. |
인플루엔자 치료제 제형
|
WO2020112716A1
(en)
|
2018-11-26 |
2020-06-04 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
DE102019134285A1
(de)
|
2019-01-15 |
2020-07-16 |
Nuuvera Deutschland GmbH |
Vorrichtung und Verfahren zum Extrahieren und Aspirieren von Wirkstoffen, insbesondere aus der Cannabispflanze
|
CN109939309B
(zh)
*
|
2019-04-01 |
2021-06-01 |
中国科学院大学深圳医院(光明) |
粉状物吸入装置
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
US11712175B2
(en)
|
2019-08-27 |
2023-08-01 |
Trudell Medical International |
Smart oscillating positive expiratory pressure device with feedback indicia
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
AU2021254045A1
(en)
|
2020-04-10 |
2022-10-13 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
EP4138884A1
(en)
|
2020-04-20 |
2023-03-01 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
CN112298819A
(zh)
*
|
2020-10-28 |
2021-02-02 |
朱爱庆 |
一种具有防潮功能的定量取药瓶
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
AU2022258576A1
(en)
|
2021-04-14 |
2023-11-02 |
Research Triangle Institute |
Hot porous-solid metering systems and methods for generation of therapeutic aerosols by evaporation/condensation
|
KR20240055745A
(ko)
|
2021-08-03 |
2024-04-29 |
코크리스탈 파마, 아이엔씨. |
코로나바이러스 억제제
|
US11517704B1
(en)
*
|
2021-12-06 |
2022-12-06 |
Stat Capsule Inc. |
Wristband capsule crusher
|
CN114098624B
(zh)
*
|
2021-12-30 |
2022-09-02 |
山东第一医科大学附属省立医院(山东省立医院) |
一种可视的直肠快速内检装置
|